Antion Biosciences is a Swiss cell and gene engineering company developing highly innovative allogeneic therapies.
Antion Biosciences has raised $109K in total funding. The most recent round was Debt Financing. The last funding was announced in April 2024.
Antion Biosciences's investors include Allogene Therapeutics, FONGIT.
Antion Biosciences is headquartered in Geneva, Switzerland.
Antion Biosciences is a Swiss cell and gene engineering company developing highly innovative allogeneic therapies.
Antion Biosciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Antion Biosciences — Funding & Investors." VCBacked, April 26, 2024, https://www.vcbacked.co/company/antion-biosciences. Accessed August 14, 2026.
VCBacked. (2024). Antion Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/antion-biosciences
{{cite web |title=Antion Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/antion-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated